ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: Eli Lilly

Lilly to acquire 2 radiopharmaceutical tracers from Siemens to grow Alzheimer’s portfolio

Lilly to acquire 2 radiopharmaceutical tracers from Siemens to grow Alzheimer’s portfolio

April 17, 2013 8:02 am by | 0 Comments

CHICAGO, April 17 (Reuters) - In a move to shore up its lead in Alzheimer's diagnostics, Eli Lilly and Co on Wednesday said it will acquire two imaging agents from ... Read more
Lilly reports positive results from two trials of diabetes drug

Lilly reports positive results from two trials of diabetes drug

April 16, 2013 9:06 am by | 0 Comments

(Reuters) - Eli Lilly and Co said two additional late-stage studies testing its experimental diabetes drug dulaglutide met the main goal of reducing hemoglobin A1c levels, a measure of blood ... Read more
Drugmaker Lilly seeks to cut 30 percent of its U.S. sales force: WSJ

Drugmaker Lilly seeks to cut 30 percent of its U.S. sales force: WSJ

April 12, 2013 12:25 am by | 0 Comments

(Reuters) - Drugmaker Eli Lilly and Co plans to layoff about 1,000 domestic sales representatives to reduce costs, as it faces daunting generic competition, the Wall Street Journal reported, citing ... Read more
Eli Lilly to double size of new plant under construction

Eli Lilly to double size of new plant under construction

April 2, 2013 11:00 am by | 1 Comments

Five months after breaking ground on a $140 million insulin plant at its Harding Street campus, Eli Lilly and Co. has decided that the plant needs to be a lot ... Read more
Eli Lilly insurer’s lawsuit says insider information led to $60 million drug heist

Eli Lilly insurer’s lawsuit says insider information led to $60 million drug heist

April 2, 2013 10:59 am by | 0 Comments

So artfully done was the overnight theft of more than $60 million worth of drugs from an Eli Lilly and Co. warehouse in Connecticut that it seemed an inside job.It ... Read more
Lilly confident on keeping dividend through patent cliff

Lilly confident on keeping dividend through patent cliff

March 6, 2013 8:48 am by | 0 Comments

BRUSSELS (Reuters) - Eli Lilly and Co will maintain its dividend despite the erosion of its earnings by generic copies of blockbuster drugs and should be well placed by the ... Read more
Obama Medicare rebate plan could hurt drug companies

Obama Medicare rebate plan could hurt drug companies

February 13, 2013 6:27 pm by | 0 Comments

(Reuters) - President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially ... Read more
Lilly stomach cancer drug extends survival vs. placebo

Lilly stomach cancer drug extends survival vs. placebo

January 23, 2013 10:41 am by | 0 Comments

(Reuters) - Eli Lilly and Co's stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study, extending the lives of patients for more than ... Read more
Lilly drug chosen for U.S.-sponsored Alzheimer’s trial

Lilly drug chosen for U.S.-sponsored Alzheimer’s trial

January 18, 2013 2:10 pm by | 0 Comments

(Reuters) - U.S. researchers said they have selected Eli Lilly and Co's experimental treatment solanezumab for a federally sponsored study of whether Alzheimer's disease can be slowed down or prevented ... Read more
Alimta patent lawsuit may be Lilly’s $15B lifeline

Alimta patent lawsuit may be Lilly’s $15B lifeline

January 4, 2013 12:04 am by | 0 Comments

NEW YORK (Reuters) - Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit.Should an ... Read more
Lilly to stop rheumatoid arthritis drug trial due to lack of efficacy

Lilly to stop rheumatoid arthritis drug trial due to lack of efficacy

December 13, 2012 8:18 am by | 0 Comments

(Reuters) - Eli Lilly and Co said it will stop one of three late-stage trials of its rheumatoid arthritis drug tabalumab due to insufficient efficacy.The decision was not based on ... Read more
Lilly’s Lundberg: It’s no longer “if” but “when” in race to find Alzheimer’s treatment

Lilly’s Lundberg: It’s no longer “if” but “when” in race to find Alzheimer’s treatment

December 11, 2012 3:47 pm by | 0 Comments

(Reuters) - Drugmaker Eli Lilly & Co is confident it will do for Alzheimer's patients what it did almost a century ago for diabetics - find a breakthrough treatment, even ... Read more
India’s Strides Arcolab and Eli Lilly form partnership to produce generic cancer drug

India’s Strides Arcolab and Eli Lilly form partnership to produce generic cancer drug

December 5, 2012 5:38 am by | 0 Comments

MUMBAI (Reuters) - India's Strides Arcolab and Eli Lilly will jointly manufacture and distribute generic cancer drugs for developing markets, the drugmakers said on Wednesday, as the U.S. company looks ... Read more
Clinicals trial database including J&J, Lily, Merck will launch by year’s end

Clinicals trial database including J&J, Lily, Merck will launch by year’s end

November 15, 2012 9:30 am by | 0 Comments

Johnson & Johnson, Merck & Co Inc and Eli Lily & Co, plan to launch a one-stop database of global clinical trial sites aimed at streamlining paperwork and speeding the ... Read more
Weak Lilly, Bristol results put pressure on pipelines

Weak Lilly, Bristol results put pressure on pipelines

October 24, 2012 11:32 am by | 0 Comments

Eli Lilly and Co and Bristol-Myers Squibb Co posted lower-than-expected profit as their former top medicines were pounded by cheaper generics and sales of other products disappointed, sending their shares ... Read more